Showing 1 - 10 of 282
All OECD countries have established vaccination programmes based on their interpretation of the risks and benefits of … diphtheria, tetanus, pertussis (whooping cough), and measles. Childhood vaccination rates reflect the percentage of children that … receive the respective vaccination in the recommended timeframe. The age of complete immunisation differs across countries due …
Persistent link: https://www.econbiz.de/10013524382
vaccination rate refers to the number of people aged 65 and older who have received an annual influenza vaccination, divided by …
Persistent link: https://www.econbiz.de/10013525916
likelihood of the emergence of viral variants of concern. Governments should therefore act now to accelerate vaccination globally …
Persistent link: https://www.econbiz.de/10012630033
vaccination, and to deliver the vaccines safely and effectively. This brief addresses the role of governments in promoting … distribute them efficiently and equitably. While only a small minority of the population holds strong anti-vaccination views …, hesitancy about COVID‑19 vaccination is evident in many countries. Recognising that vaccination campaigns of the magnitude …
Persistent link: https://www.econbiz.de/10012630069
All countries need vaccines but not all can produce them. Vaccine production is highly specialised, subject to comparative advantages, and concentrated in few countries, making trade a vital means to deploying vaccines broadly. Keeping markets open by reducing tariffs, streamlining trade-related...
Persistent link: https://www.econbiz.de/10012630122
This brief discusses policies needed to ensure equitable and universal access by all those in need globally to future vaccines for SARS-Cov-2, the virus that causes COVID-19, and treatments for the disease. It provides a snapshot of the vaccine and drug candidates in the current R&D pipeline. It...
Persistent link: https://www.econbiz.de/10012630217
As the roll out of coronavirus (COVID-19) vaccines begins, this policy brief asks how to ensure vaccines for all. In doing so, it examines the case for multilateral approaches to access and delivery, maps key challenges, and identifies priority actions for policy makers. The absence of a...
Persistent link: https://www.econbiz.de/10012630284
Pandemic preparedness and response are quintessential “global public goods”: unless the new coronavirus is controlled everywhere, the risk of pandemic resurgence remains. This paper presents the key role of development finance in helping developing countries’ health systems prepare and...
Persistent link: https://www.econbiz.de/10012630356
In developing countries, 6 out of 10 people die from infectious diseases. Nearly 1 billion humans suffer from a neglected infectious disease, according to the World Health Organisation. Yet less than 1% of the new drugs placed on the market from 1975 to the turn of the century were developed for...
Persistent link: https://www.econbiz.de/10012448189
Persistent link: https://www.econbiz.de/10015054455